Flubrotizolam presents itself as a novel benzodiazepine analogue. Introduced for medical purposes, flubrotizolam possesses powerful anxiolytic effects. Its pharmacological properties demonstrate a high affinity for the GABA receptor, resulting significant CNS depression. Although its potential therapeutic applications, flubrotizolam's non-medical u